Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease

Sponsor
Nanjing First Hospital, Nanjing Medical University
Study ID
NCT07764094
Status
Recruiting
Apply to this trial

Conditions

  • Coronary Artery Disease
  • Drug-coated Balloon
  • PCI

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Study Details

This registry aimed to investigate drug-coated balloon procedural factors (particularly delivery time and inflation duration) to evaluate the impact on angiographic and clinical outcomes in patients undergoing percutaneous coronary intervention for de novo coronary lesions.

Key Dates

First listed
Aug 13, 2026
Start date
Sep 1, 2026
Status verified
Aug 2026
Primary completion
Dec 31, 2027
Completion
Jun 30, 2028

Study Design

Enrollment
500 participants (estimated)

Arms

  • Arm: DCB-Treated De Novo Lesion
    Patients undergoing drug-coated balloon treatment for de novo coronary lesions

Primary Outcome Measure

Number of Participants with Target Lesion Restenosis [ Time Frame: 6-12 months ]

Central Contacts

Related Studies